These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35792231)

  • 1. Exploiting mesoporous silica, silver and gold nanoparticles for neurodegenerative diseases treatment.
    Ribeiro TC; Sábio RM; Carvalho GC; Fonseca-Santos B; Chorilli M
    Int J Pharm; 2022 Aug; 624():121978. PubMed ID: 35792231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles.
    Tian Y; Qi J; Zhang W; Cai Q; Jiang X
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):12038-45. PubMed ID: 25050635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticle-capped mesoporous silica-based H
    Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
    Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-templated in situ growth of silver nanoparticles on mesoporous silica nanospheres for smart intracellular GSH-controlled release.
    Liu C; Qing Z; Zheng J; Deng L; Ma C; Li J; Li Y; Yang S; Yang J; Wang J; Tan W; Yang R
    Chem Commun (Camb); 2015 Apr; 51(30):6544-7. PubMed ID: 25765340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver nanoparticle gated, mesoporous silica coated gold nanorods (AuNR@MS@AgNPs): low premature release and multifunctional cancer theranostic platform.
    Zhang Z; Liu C; Bai J; Wu C; Xiao Y; Li Y; Zheng J; Yang R; Tan W
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6211-9. PubMed ID: 25707533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
    Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
    Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment.
    Carvalho GC; Sábio RM; de Cássia Ribeiro T; Monteiro AS; Pereira DV; Ribeiro SJL; Chorilli M
    Pharm Res; 2020 Sep; 37(10):191. PubMed ID: 32895867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-Induced Hydrogel Based on Tumor-Targeting Mesoporous Silica Nanoparticles as a Theranostic Platform for Sustained Cancer Treatment.
    Chen X; Liu Z; Parker SG; Zhang X; Gooding JJ; Ru Y; Liu Y; Zhou Y
    ACS Appl Mater Interfaces; 2016 Jun; 8(25):15857-63. PubMed ID: 27265514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Biological Degradation Behavior of Stöber Mesoporous Silica Nanoparticles from Their Interiors to Their Exteriors.
    Chen G; Teng Z; Su X; Liu Y; Lu G
    J Biomed Nanotechnol; 2015 Apr; 11(4):722-9. PubMed ID: 26310078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver Mesoporous Silica Nanoparticles: Fabrication to Combination Therapies for Cancer and Infection.
    He X; Chen F; Chang Z; Waqar K; Hu H; Zheng X; Wang Y; Dong WF; Yang C
    Chem Rec; 2022 Apr; 22(4):e202100287. PubMed ID: 35020240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled drug release with surface-capped mesoporous silica nanoparticles and its label-free in situ Raman monitoring.
    Lee S; Kwon JA; Park KH; Jin CM; Joo JB; Choi I
    Eur J Pharm Biopharm; 2018 Oct; 131():232-239. PubMed ID: 30165104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery.
    Fateh Basharzad S; Hamidi M; Maleki A; Karami Z; Mohamadpour H; Reza Saghatchi Zanjani M
    Brain Res; 2022 Apr; 1781():147786. PubMed ID: 35041841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-Decorated Gold Nanoparticles as Functional Nano-Capping Agent of Mesoporous Silica Container for Targeting Drug Delivery.
    Chen G; Xie Y; Peltier R; Lei H; Wang P; Chen J; Hu Y; Wang F; Yao X; Sun H
    ACS Appl Mater Interfaces; 2016 May; 8(18):11204-9. PubMed ID: 27102225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile Fabrication Route of Janus Gold-Mesoporous Silica Nanocarriers with Dual-Drug Delivery for Tumor Therapy.
    Xing Y; Zhou Y; Zhang Y; Zhang C; Deng X; Dong C; Shuang S
    ACS Biomater Sci Eng; 2020 Mar; 6(3):1573-1581. PubMed ID: 33455359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks.
    Baeza A; Ruiz-Molina D; Vallet-Regí M
    Expert Opin Drug Deliv; 2017 Jun; 14(6):783-796. PubMed ID: 27575454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cell targeting and therapeutic delivery of silver nanoparticles by mesoporous silica nanocarriers: insights into the action mechanisms using quantitative proteomics.
    Montalvo-Quiros S; Aragoneses-Cazorla G; Garcia-Alcalde L; Vallet-Regí M; González B; Luque-Garcia JL
    Nanoscale; 2019 Mar; 11(10):4531-4545. PubMed ID: 30806414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.